Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (opent nieuw venster)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Bron‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Geïndexeerd‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (opent nieuw venster)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (opent nieuw venster)

Banan M.

Bron‎: Ann Hematol 2013;92(3):289-99.

Geïndexeerd‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (opent nieuw venster)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (opent nieuw venster)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Bron‎: Transfusion 2007;47(10):1830-6.

Geïndexeerd‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (opent nieuw venster)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (opent nieuw venster)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Bron‎: Blood 1996;87(3):887-92.

Geïndexeerd‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (opent nieuw venster)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (opent nieuw venster)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Bron‎: Iran J Blood Cancer 2009;1(4):147-50.

Geïndexeerd‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (opent nieuw venster)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (opent nieuw venster)

Karimi M, Cohan N, Pishdad P.

Bron‎: Hematology 2015;20(1):53-7.

Geïndexeerd‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (opent nieuw venster)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (opent nieuw venster)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Bron‎: Int J Hematol 2012;95(1):51-6.

Geïndexeerd‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (opent nieuw venster)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (opent nieuw venster)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Bron‎: Hemoglobin 2014;38(2):115-8.

Geïndexeerd‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (opent nieuw venster)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (opent nieuw venster)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Bron‎: Blood 2013;121(12):2199-212.

Geïndexeerd‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (opent nieuw venster)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (opent nieuw venster)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Bron‎: Sci Rep. 2022;12(1):2752.

Geïndexeerd‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (opent nieuw venster)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (opent nieuw venster)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Bron‎: Haematologica 2004;89(10):1172-8.

Geïndexeerd‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (opent nieuw venster)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (opent nieuw venster)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Bron‎: Arch Iran Med 2009;12(3):295-7.

Geïndexeerd‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (opent nieuw venster)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (opent nieuw venster)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Bron‎: Eur J Haematol 1996;56(5):326-8.

Geïndexeerd‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (opent nieuw venster)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (opent nieuw venster)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Bron‎: J Matern Fetal Med 1999;8(1):1-7.

Geïndexeerd‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (opent nieuw venster)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (opent nieuw venster)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Bron‎: Acta Haematol 2004;111(4):189-95.

Geïndexeerd‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (opent nieuw venster)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (opent nieuw venster)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Bron‎: Ann Hematol 2001;80(8):492-5.

Geïndexeerd‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (opent nieuw venster)

Fetal globin induction--can it cure beta thalassemia? (opent nieuw venster)

Perrine SP.

Bron‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Geïndexeerd‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (opent nieuw venster)